Urihk Pharmaceuticals
  • Home
  • About Us
    • Our Team
    • The Urihk Partnership
  • Products
    • Antibiotic
    • Antifungal
    • Antioxidant
    • Immuno modulator
    • Neuro/CNS
  • Services
  • Learn More
    • News
    • Gallery
    • Careers
  • Contact Us
Select Page
Back
The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial
Oct 23, 2021

The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial

Comparison of fondaparinux (FPX) and low molecular weight heparin (LMWH) in the treatment of portal vein thrombosis in cirrhosis
Oct 23, 2021

Comparison of fondaparinux (FPX) and low molecular weight heparin (LMWH) in the treatment of portal vein thrombosis in cirrhosis

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism
Oct 23, 2021

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism

The safety of fondaparinux sodium for the treatment of venous thromboembolism
Oct 23, 2021

The safety of fondaparinux sodium for the treatment of venous thromboembolism

ABOUT URIHK

URIHK pharmaceuticals is a wholly owned subsidiary of UREKA Hong Kong Ltd. We are a vertically integrated pharmaceutical company that launches, registers and distributes innovative products in India.
 

SITEMAP

About Us

Services

Products

Careers

Privacy Policy

CONTACT US

602-603, Sai Samarth Business Park,
Deonar, Govandi (East),
Mumbai (400088), India
Phone: +91 22 497 01103 / 43286
Email: [email protected]